Evidence map›Paper›PMID 42908002›Full record

ArticleBMC nursing2026

Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives.

Monica Scharfenort, Anette Nobrell, Michela Garon, Kristina Rosqvist, Gesine Paul, Maria H Nilsson, Angelo Antonini, Dag Nyholm, Per Odin, Elisabeth Mangrio

Abstract read
In one paragraph

Article in BMC nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monica ScharfenortDepartment of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden. monica.scharfenort@med.lu.se.ORCID http://orcid.org/0000-0003-4415-1428
Anette NobrellDepartment of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Michela GaronNeurodegenerative Disease Unit, Center for Rare Neurological Diseases (ERN- RND), Department of Neurosciences, Padua Neuroscience Center (PNC), University of Padova, Padova, Italy.
Kristina RosqvistDepartment of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
Gesine PaulDepartment of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
Maria H NilssonDepartment of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Angelo AntoniniNeurodegenerative Disease Unit, Center for Rare Neurological Diseases (ERN- RND), Department of Neurosciences, Padua Neuroscience Center (PNC), University of Padova, Padova, Italy.
Dag NyholmDepartment of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Per OdinDepartment of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
Elisabeth MangrioDepartment of Care Sciences, Malmö University, Malmö, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is a progressive neurodegenerative disorder affecting motor and non-motor functions. When oral medication no longer provides adequate control, device-aided therapies (DAT), including levodopa infusion therapy, may be introduced. Although DAT can improve symptom management, little is known about how people with PD (PwPD) and family caregivers (FC) experience the initiation process. This study explored PwPD and their FC perceptions during decision-making, therapy initiation, and subsequent adaptation to levodopa pump therapy.

methodsThis qualitative study employed semi-structured interviews (6-24 months after treatment initiation) and latent reflexive thematic analysis with ten PwPD and nine FC recruited from two Swedish university hospitals.

resultsThematic analysis revealed four shared themes: (1) Living with the constraints of PD, (2) Sustaining hope in the face of therapeutic uncertainty, (3) Adapting to a new treatment while facing practical challenges, and (4) Relying on expertise while managing its absence. Pump therapy was often chosen due to limited alternatives and strong trust in the specialized multidisciplinary PD team. While both groups experienced symptom improvements, PwPD focused on autonomy whereas FC focused on responsibilities. Expectations were generally met, yet FC frequently felt underinformed about the realities of daily pump management.

conclusionsOur findings highlight that although symptom control improved, both PwPD and FC continued to face practical and emotional challenges. Supporting their adaptation process requires coordinated, person-centred preparation, guidance and follow-up from multidisciplinary, specialized PD teams. CLINICAL

trial registrationNot applicable.

Indexed as

ExpectationsFamily caregiversInfusionLived experiencesParkinson’s diseasePatientsPump therapyQualitative researchSatisfaction

Identifiers

PMID42908002
PMCPMC13689137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.